Then, we validated the findings on GSCs isolated from glioblastoma cell lines by using PIP to inhibit survivin in these cells and observed the effect on various cancer processes including self-renewal, proliferation, invasion, apoptosis and resistance to standard of care drug TMZ. This evidence concerns the gene BIRC5 and cancer.